Steinar Aamdal
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Lung Cancer Research Studies
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 65
- Cancer Immunotherapy and Biomarkers 22
- Cutaneous Melanoma Detection and Management 16
- Cancer Treatment and Pharmacology 7
- Immunology 42
- Immunotherapy and Immune Responses 30
- Toxin Mechanisms and Immunotoxins 7
- Co-authors
- Gustav Gaudernack (20 shared papers)Øystein Fodstad (19 shared papers)Alexander Pihl (14 shared papers)Gunnar Kvalheim (16 shared papers)Jean‐Jacques Grob (3 shared papers)Stein Sundstrøm (7 shared papers)Jon Amund Kyte (11 shared papers)Paal Brunsvig (14 shared papers)
- Journals
- Journal of Clinical Oncology (21 papers)European Journal of Cancer (14 papers)Cancer Chemotherapy and Pharmacology (7 papers)British Journal of Cancer (7 papers)Cancer Immunology Immunotherapy (6 papers)
- Partner nations
- NorwayUnited KingdomGermany
In The Last Decade
Steinar Aamdal
127 papers receiving 6.4k citations
Steinar Aamdal's Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 3.5k
- Immunology 2.0k
- Molecular Biology 2.5k
- Biotechnology 302
- Genetics 269
Countries citing papers authored by Steinar Aamdal
This map shows the geographic impact of Steinar Aamdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steinar Aamdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steinar Aamdal more than expected).
Fields of papers citing papers by Steinar Aamdal
This network shows the impact of papers produced by Steinar Aamdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steinar Aamdal. The network helps show where Steinar Aamdal may publish in the future.
Co-authors
The 25 scholars most cited alongside Steinar Aamdal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma Hit paper breakdown → | 2000 | 938 |
| 2 | 2011 | 444 | |
| 3 | Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial Hit paper breakdown → | 2015 | 374 |
| 4 | 2004 | 355 | |
| 5 | 2002 | 347 | |
| 6 | 2013 | 260 | |
| 7 | 2006 | 196 | |
| 8 | Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. | 1992 | 181 |
| 9 | 2006 | 163 | |
| 10 | 2003 | 146 | |
| 11 | 1998 | 138 | |
| 12 | 2002 | 135 | |
| 13 | 2011 | 132 | |
| 14 | 2004 | 116 | |
| 15 | 2013 | 113 | |
| 16 | 1988 | 97 | |
| 17 | 2011 | 92 | |
| 18 | 2011 | 80 | |
| 19 | Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells. | 1988 | 78 |
| 20 | 2013 | 77 |
About Steinar Aamdal
Steinar Aamdal is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 128 papers that have together received 6.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (30 papers), Cancer Immunotherapy and Biomarkers (22 papers), Cutaneous Melanoma Detection and Management (16 papers), Cancer Research and Treatments (9 papers), Melanoma and MAPK Pathways (8 papers), Toxin Mechanisms and Immunotoxins (7 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Oncology (3.5k citations), Immunology (2.0k citations), Molecular Biology (2.5k citations), Biotechnology (302 citations) and Genetics (269 citations). Steinar Aamdal has collaborated with scholars based in Norway, United Kingdom and Germany. Frequent co-authors include Gustav Gaudernack, Øystein Fodstad, Alexander Pihl, Gunnar Kvalheim, Jean‐Jacques Grob, Stein Sundstrøm, Jon Amund Kyte, Paal Brunsvig, Roy M. Bremnes and Stein Kaasa. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Cancer Chemotherapy and Pharmacology, British Journal of Cancer and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.